RBM47 and central nervous system cancer: In addition, RBM47 expression was notably higher in isocitrate dehydrogenase (IDH)-wild-type glioma samples, those without 1p/19q co-deletion, and those devoid of methylguanine-DNA methyltransferase promoter methylation (Fig. 2B–D).